Chief Executive Officer, Nu-Vision Biotherapies
Andy is CEO of NuVision Biotherapies, a tissue-based therapy business that was spun out of the University of Nottingham in 2015. The company provides therapeutic solutions for patients living with a range of acute and chronic conditions in ophthalmology. The company’s platform tissue processing technology is extending significantly the clinical indications for human tissue-derived therapies, simplifying logistics and storage whilst preserving their natural healing properties.
A life-sciences graduate and MBA with over 30 years’ experience in the medical technology industry as an executive and entrepreneur, Andy’s background is in sales, marketing and general management and he has a track record in the introduction of new and disruptive medical technologies into Europe and the USA.
Andy built the European businesses (from first in human use to exit) for two US start-ups and has led businesses (private and PLC) as a CEO across a diverse range of sectors including patient monitoring, imaging and AI. He cofounded and was an investor in an Oxford University spinout.
Andy is a drummer and played professionally for a period during his misspent youth. He continues to play regularly.